Furthermore, with age, gender, and tumor location as covariates, multivariate Cox regression analysis indicated that highly expressed ZEB1-AS1 (HR = 1.885, 95% CI: 1.068–3.326, p = 0.029) and the clinical stage (HR = 1.791, 95% CI: 1.016–3.158, p = 0.044) were independent prognostic factors for overall survival of glioma prognosis (Table 2). This evidence concerns the gene ZEB1 and glioma.